Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04064970 · ClinicalTrials.gov registry record
Patient Satisfaction Survey of Non-surgical Urinary Incontinence Treatment
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 125
- Enrollment target
NCT04064970: Completed study, sponsored by University of Rochester.
NCT04064970 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04064970 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to identify self-reported wellness following nonsurgical treatment of stress urinary incontinence. This will be done by correlating the response of "yes" on the patient acceptable symptom state (PASS) question to responses from other questionnaires regarding urinary symptoms.
Primary Outcome
Each participant will be asked to complete the Urinary Distress Inventory 6 (UDI-6) after enrollment and again after 6 weeks. This is a short validated disease-specific patient reported outcome measuring urinary incontinence severity. The UDI-6 is a likert scale based questionnaire that calculates the mean of the scores and multiplies that mean by 25 to scale the instrument to an "actual score" with a range of 0 - 100. The higher the score the greater perceived negative impact on an individual's
Interventions
- BEHAVIORAL patient acceptable symptom state (PASS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2019-03-14 |
| Est. Completion | 2020-07-01 |
What the finished NCT04064970 record still lists
NCT04064970 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which patient acceptable symptom state (PASS) is the first listed.
NCT04064970 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04064970 about?
NCT04064970 is a clinical study titled "Patient Satisfaction Survey of Non-surgical Urinary Incontinence Treatment". The purpose of this study is to identify self-reported wellness following nonsurgical treatment of stress urinary incontinence. This will be done by correlating the response of "yes" on the patient acceptable symptom state (PASS) question to responses from other questionnaires regarding urinary symp...
What is the current status of trial NCT04064970?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2019-03-14. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT04064970?
The interventions under investigation include: patient acceptable symptom state (PASS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04064970?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI